Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute
Advertisement
Articles by Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute
Advertisement
Latest Updated Articles
Rapid Readouts: Phase 1/2 KRYSTAL-1 TrialPublished: November 18th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
3
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
4
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
5